Publication date: November 2022Source: Journal of Behavioral and Cognitive Therapy, Volume 32, Issue 4Author(s): Liang Ma, Yanjie Wang, Le Pan, Zeshi Cui, Philip J. Schluter
To the Editor Hoge et al composed a well-written and interesting study examining the effect of mindfulness-based stress reduction (MBSR) vs escitalopram for the treatment of anxiety disorders. A prominent finding was that in adults with anxiety disorders, 8 weeks’ treatment with MBSR was noninferior to escitalopram.
Introduction The purpose of this systematic review was to examine the efficacy of mindfulness-based interventions for improving anxiety, social skills, and aggressive behaviors in children and young people (CYP) with Autism Spectrum Disorder (ASD); summarize the results across clinic, home, and school contexts; and evaluate the quality of these interventions for clinical practice. Methods A
Excerpted from “In Sickness: A Memoir” by Barrett Rollins, Chief Scientific Officer, Emeritus, Dana-Farber Cancer Institute and Linde Family Professor of Medicine, Harvard Medical School.
Excerpt from Barrett Rollins’ ‘In Sickness’ Read More »
Another in series of pieces about resetting our lives for a healthier new year. Excerpted from “Why We Meditate: The Science and Practice of Clarity and Compassion” by Daniel Goleman, Ph.D. ’74, and Tsoknyi Rinpoche, with Adam Kane.
Excerpt from ‘Why We Meditate’ Read More »
